KLF5 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.00799999999979E-05 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.717200E-03 |
Normal-vs-Stage2 |
1.850250E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.016500E-02 |
Stage1-vs-Stage2 |
9.157200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.410400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.517800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.951100E-04 |
Normal-vs-AfricanAmerican |
1.827840E-01 |
Normal-vs-Asian |
1.197000E-01 |
Caucasian-vs-AfricanAmerican |
7.431600E-01 |
Caucasian-vs-Asian |
9.395200E-01 |
AfricanAmerican-vs-Asian |
6.843800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.260280E-03 |
Normal-vs-Female |
7.081100E-03 |
Male-vs-Female |
9.960600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.920000E-03 |
Normal-vs-Extreme_Weight |
2.137500E-03 |
Normal-vs-Obese |
3.680300E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.416200E-01 |
Normal_Weight-vs-Obese |
3.120000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
4.951600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.125000E-01 |
Normal-vs-Age(41-60Yrs) |
1.138000E-02 |
Normal-vs-Age(61-80Yrs) |
7.587800E-04 |
Normal-vs-Age(81-100Yrs) |
4.747200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.544200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.973200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.899200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.732100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.325000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.490200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.616600E-01 |
Normal-vs-Grade 3 |
3.844200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.346000E-01 |
Grade 2-vs-Grade 4 |
6.616600E-01 |
Grade 3-vs-Grade 4 |
3.844200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.497890E-03 |
Normal-vs-N1 |
6.136300E-02 |
N0-vs-N1 |
2.399600E-01 |
|
|